Rights offering for common stock
Company: Core Scientific
The claim, verbatim
Core Scientific authorized holders of old common stock as of November 16, 2023 to participate in a rights offering to purchase up to $55 million of Common Stock pursuant to the reorganization plan
Source (primary)
Core Scientific SC 13D/A filed 2024-02-20 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the "Rights Offering") for the purchase, on a pro rata basis, of up to $55 million of Common Stock to be issued pursuant to the Plan.”
How we checked this
Checked on September 18, 2026. The cited source supports every part of this claim.
The filing states that, under the Plan, holders of old common stock as of November 16, 2023 were granted the right to take part in a rights offering for up to $55 million of Common Stock.
Confirmed in the source:
- Under Core Scientific's reorganization plan, holders of its old common stock as of November 16, 2023 were granted the right to participate in a rights offering
- The rights offering was for the purchase of up to $55 million of Common Stock to be issued pursuant to the plan
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524040126/d746411dsc13da.htm) in full (26,286 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific SC 13D/A filed 2024-02-20
Quote: “holders of the Issuer's Old Common Stock as of November 16, 2023 were granted the right to participate in a rights offering (the "Rights Offering") for the purchase, on a pro rata basis, of up to $55 million of Common Stock to be issued pursuant to the Plan.”